| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |